Stephen Basil Thomas - Director at Climb Bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
CLYM on Nasdaq
All Insider Reports
All Insider Reports

Stephen Basil Thomas - trading volume in the past year for Climb Bio, Inc.

Holdings reported by Stephen Basil Thomas for Climb Bio, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 204,657 $1,189,896 $5.81 13 Feb 2026 Direct
Restricted Stock Units 0 $32,873 $1.31 27 Jun 2025 Direct Common Stock
Stock Option (Right to Buy) 40,000 04 Jun 2025 Direct Common Stock

Transactions reported by Stephen Basil Thomas for Climb Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.